IGF-1 LR3 is recommended to patients with the following conditions: hormone deficiency in children that results in short stature, adult growth deficiency, short bowel syndrome, short stature due to Turner Syndrome, adult deficiency associated with pituitary tumors or treatment of these tumors and muscle-wasting disease related to HIV/AIDS [10]
Patients should report symptoms such as a lump in the neck, hoarseness, difficulty swallowing, or shortness of breath
There are no adequate data or clinical studies of semaglutide use for the treatment of type 2 diabetes mellitus (T2DM) in pregnant women to inform a drug-associated risk for adverse developmental outcomes
The body enters a state of "metabolic resistance," where it becomes increasingly efficient at storing fat and resistant to burning it
Although night sweats are not a recognised side effect of Mounjaro, several theoretical mechanisms might potentially contribute to nocturnal perspiration in some patients